XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
110 hedge funds and large institutions have $660M invested in Intersect ENT, Inc in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 41 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
17% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 41
Holders
110
Holding in Top 10
2
Calls
$5.45M
Puts
$3.5M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$12.7M | |
| 3 | +$11.1M | |
| 4 |
BlackRock
New York
|
+$5.4M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$4.58M |
Top Sellers
| 1 | -$30.2M | |
| 2 | -$9.77M | |
| 3 | -$5.65M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.72M |